1859
Minyan Li has been employed by three companies. In 2018, they began working as a Research Associate at The Scripps Research Institute, where they conducted C-H activation research at Prof. Jin-quan Yu's lab and fully applied High-Throughput-Screening into the reaction development. In 2019, they moved to The Janssen Pharmaceutical Companies of Johnson & Johnson, where they worked as a Scientist. In 2022, they began working as the Director of High Throughput Experimentation, Automation Chemistry for 1859 Inc.
Minyan Li began their education in 2007 when they earned a Bachelor's degree in Chemistry from Nankai University. Following this, they attended the University of Pennsylvania, where they earned a Doctor of Philosophy - PhD in Organic Chemistry in 2017. Minyan is currently pursuing a Master's degree in Computer Science at the Georgia Institute of Technology, which they are expected to complete in 2024.
This person is not in any teams
This person is not in any offices
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.